BioSpace News Archive

Business

Avalo Reports First Quarter 2023 Financial Results and Provides Business Updates

Avalo Therapeutics, Inc., announced business updates and financial results for the first quarter of 2023.

May 4, 2023
·
9 min read
Business

Sight Sciences Reports First Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023

Sight Sciences, Inc., an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, reported financial results for the first quarter ended March 31, 2023 and reaffirmed guidance for full year 2023.

May 4, 2023
·
11 min read
Business

Vaxart Provides Business Update and Reports First Quarter 2023 Financial Results

Vaxart, Inc. announced its business update and financial results for the first quarter of 2023.

May 4, 2023
·
10 min read
Business

NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data

NGM Biopharmaceuticals, Inc., a clinical-stage biotechnology company focused on discovering and developing transformative therapeutics for patients, reported financial results for the quarterly period ended March 31, 2023 and provided business highlights.

May 4, 2023
·
11 min read
Business

Curis Provides First Quarter 2023 Business Update

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported its business update and financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
12 min read
Business

Tyra Biosciences Reports First Quarter 2023 Financial Results and Highlights

Tyra Biosciences, Inc., a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor biology, reported financial results for the quarter ended March 31, 2023 and highlighted recent corporate progress.

May 4, 2023
·
8 min read
Bio NC

Congruence Therapeutics to Present at Multiple Investor Conferences in May 2023

Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding, announced that management will participate in the following investor conferences.

May 4, 2023
·
1 min read
Business

Artivion Reports First Quarter 2023 Financial Results

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
16 min read
Genetown

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - May 04, 2023

Syndax Pharmaceuticals, Inc. announced that on May 1, 2023 the Company granted inducement awards to purchase up to 272,000 shares of common stock to fifteen new employees under the Company’s 2023 Inducement Plan.

May 4, 2023
·
1 min read
Business

Cryoport Reports First Quarter 2023 Results

Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences, announced financial results for the three months ended March 31, 2023.

May 4, 2023
·
26 min read